Search research articles
Contact Us
Filters
Showing results (101-110 of 149) with videos related to
Page
of 15
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
June 12, 2020
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study
Zeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.
Cancers
|
December 30, 2025
Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG)
Ülkü Yalçıntaş Arslan, Ferit Aslan, Murat Ayhan, et al.
Medical Oncology (Northwood, London, England)
|
May 17, 2011
Outcome of non-metastatic male breast cancer: 118 patients
Ulkü Yalçıntaş Arslan, Berna Oksüzoğlu, Nuriye Ozdemir, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. <i>Medicina</i> 2025, <i>61</i>, 638
Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Medicina (Kaunas, Lithuania)
|
April 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study
Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Anticancer Research
|
July 31, 2014
Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial
Ibrahim Yildiz, Meltem Ekenel, Tulay Akman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
August 20, 2019
The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study
Muhammet Ali Kaplan, Zeynep Oruc, Mahmut Gumus, et al.
Journal of Chemotherapy (Florence, Italy)
|
October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2012
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer
Ramazan Yildiz, Mustafa Benekli, Metin Ozkan, et al.
Medical Oncology (Northwood, London, England)
|
June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients
Emin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 149) with videos related to
Sort By:
Page
of 15
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
June 12, 2020
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study
Zeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.
Cancers
|
December 30, 2025
Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG)
Ülkü Yalçıntaş Arslan, Ferit Aslan, Murat Ayhan, et al.
Medical Oncology (Northwood, London, England)
|
May 17, 2011
Outcome of non-metastatic male breast cancer: 118 patients
Ulkü Yalçıntaş Arslan, Berna Oksüzoğlu, Nuriye Ozdemir, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. <i>Medicina</i> 2025, <i>61</i>, 638
Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Medicina (Kaunas, Lithuania)
|
April 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study
Ziya Kalkan, Senar Ebinc, Murat Arcagok, et al.
Anticancer Research
|
July 31, 2014
Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial
Ibrahim Yildiz, Meltem Ekenel, Tulay Akman, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
August 20, 2019
The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study
Muhammet Ali Kaplan, Zeynep Oruc, Mahmut Gumus, et al.
Journal of Chemotherapy (Florence, Italy)
|
October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2012
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer
Ramazan Yildiz, Mustafa Benekli, Metin Ozkan, et al.
Medical Oncology (Northwood, London, England)
|
June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients
Emin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
Page
of 15